Combination drug therapy for childhood brain tumors shows promise in laboratory models
(Johns Hopkins Medicine) In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Childhood Cancer | Glioma | International Medicine & Public Health | Laboratory Medicine | Neurology | Pediatrics